Many Generic Drugs Haven’t Hit Market, Hindering Cost-Control Efforts

📆 20/11/2019 04:00:00
📰 WSJ

⏱ Reading Time:
9 sec. here
2 min. at publisher
📊 Quality Score:
News: 7%
Publisher: 63%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

To curb high drug costs, the U.S. has approved record numbers of generic drugs in recent years. But only a fraction have gone on sale.

Record numbers of generic drugs for cancer, heart ailments and other conditions have received U.S. approval in recent years, raising hopes that the new competition would reduce high drug costs. But many of the lower-price medicines haven’t hit the market, a Wall Street Journal review found.

The result: Many patients are forced to take high-price medicines, and a widely touted remedy for reining in drug costs has failed to live up to its promise.

Écrire un Commentaire

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Double-whammy of Brexit and election hits UK housing market - surveyThe number of properties put up for sale in Britain has fallen by the most in an...
La source: Reuters - 🏆 2. / 97 Lire la suite »